Local Business Alert: GlaxoSmithKline buys Human Genome Sciences for $3.6B

	Monday, July 16, 2012 11:20:42 AM LOCAL BUSINESS ALERT GlaxoSmithKline buys Human Genome Sciences for $3.6B British drugmaker GlaxoSmithKline has agreed to pay $3.6 billion for Rockville-based Human Genome Sciences after a months-long acquisition dispute over the company's true value. Glaxo has extended multiple buyout offers since April to both the HGS board of directors and its shareholders that valued the company at $2.6 billion, or $13 per share, but the company repeatedly rejected them as too low. Read more at: http://www.washingtonpost.com/blogs/capital-business/post/glaxosmithkline-buys-human-genome-sciences-for-36b/2012/07/16/gJQAW9JfoW_blog.html Or visit Capital Business or the Local Business section on washingtonpost.com. SEND TO A FRIEND UNSUBSCRIBE E-MAIL CENTER GET HELP Washington Post Digital E-mail Customer Care 1150 15th Street NW Washington, D.C. 20071  ©2011 The Washington Post Privacy Policy